Structure |
Chemical Name |
CAS |
MF |
|
blonanserin impurity O |
|
|
|
Butyphthalide impurity 42 |
952412-79-2 |
C10H12O3 |
|
Butyphthalide impurity 48 |
|
|
|
Dapoxetine impurity 20 |
|
|
|
2-((4-(カルボキシメチル)フェノキシ)メチル)安息香酸 |
55453-89-9 |
C16H14O5 |
|
Ipragliflozin Impurity 5 |
|
|
|
Ibrutinib Impurity 18 |
1881246-01-0 |
C16H12N4O |
|
Vitamin B1 Impurity 6 |
|
C12H17ClN4OS |
|
5,5'-((tert-butylazanediyl)bis(1-hydroxyethane-2,1-diyl))bis(benzene- 1,3-diol) |
|
C20H27NO6 |
|
2,2'-difluoro-3,3'-dimethoxy-1,1'-biphenyl |
2316733-82-9 |
C14H12F2O2 |
|
nicergoline impurity N |
|
|
|
Clopidogrel Impurity 50 |
|
C15H14ClNO2S |
|
PraMipexole IMpurity Z1/Z2 |
|
|
|
trans-Ibuprofen Impurity G |
|
C13H18O2 |
|
Vonoprazan Impurity 15 |
|
|
|
Erlotinib Impurity 22 |
|
|
|
Teneligliptin Impurity 1 |
|
|
|
Erlotinib Hydrochloride iMpurity 51 |
|
|
|
(S)-10-(1-aminocyclopropyl)-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid formic acid |
|
C17H18N2O6 |
|
1H-Imidazole-1-ethanol, α-(chloromethyl)-5-nitro- |
116989-52-7 |
C6H8ClN3O3 |
|
4-Pyridinemethanol, 3-hydroxy-2,5-dimethyl-, hydrochloride (1:1) |
875-26-3 |
C8H11NO2.ClH |
|
5α-アンドロスタ-3-エン-17-オン |
14935-81-0 |
C19H28O |
|
Landiolol impurity X |
|
|
|
2-((4-(3-aminopiperidin-1-yl) |
|
|
|
Rosuvastatin Impurity 111 |
|
|
|
Metoprolol IMpurity V |
|
C15H25NO3 |
|
Teneligliptin Impurity 12 |
|
|
|
Nicergoline EP Impurity E |
|
|
|
Hexanoic acid, 3-[(hydroxyamino)methyl]-5-methyl-, (3S)- |
2349671-57-2 |
C8H17NO3 |
|
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate |
714269-58-6 |
C30H35ClO11 |
|
Caspofungin Impurity H |
|
|
|
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine hydrochloride |
127017-41-8 |
C21H26ClNO4 |
|
Ezetimibe Impurity 76 |
1185883-46-8 |
C39H44F2N2O5Si |
|
Cefmetazole impurity 9/(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-(hydroxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid |
70953-19-4 |
C13H15N3O6S2 |
|
((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate |
|
C20H24FNO3S |
|
Elagolix Sodium impurity1 |
|
|
|
Ibrutinib Impurity 37 |
330793-49-2 |
C10H13IN6 |
|
(S)-((6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)amino)methanol |
|
C11H19N3OS |
|
(trans)-4-((6-amino-2,3-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
ERYTHROMYCIN IMPURITY N |
|
|
|
Fesoterodine Impurity 12 |
|
|
|
Dexamethasone EP impurities D |
|
|
|
Palbociclib impurity LMAP |
|
|
|
(3R,3'R)-3,3'-((((S)-1-amino-1-oxobutan-2-yl)azanediyl)bis(methylene))dihexanoic acid |
|
C18H34N2O5 |
|
Acetaminophen EP Impurity L |
|
C8H9NO2 |
|
(R)-4-(2-(benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol |
317351-40-9 |
C16H19NO3 |
|
N,N'-Bis(4-hydroxyphenyl)hydrazine |
158905-63-6 |
C12H12N2O2 |
|
Droxidopa Impurity M |
|
|
|
Aripiprazole peroxide degradation Impurity (MW:464Da) |
|
|
|
Zileuton Impurity (MW = 279.31 Da) |
|
|
|
Rivaroxaban Impurity 81 |
|
|
|
Gadobutrol Impurity 21 |
|
|
|
Flucloxacillin sodium EP Impurity E |
|
|
|
Pyrazole |
|
|
|
Cephalomannine (Paclitaxel Impurity I) |
|
|
|
METOPROLOL IMPURITY D |
|
C15H25NO3 |
|
NITRENDIPINE IMPURITY A |
|
|
|
TAMSULOSIN IMPURITY D |
|
C20H28N2O5S |
|
Macitentan Hydroxy amine Impurity |
2211059-05-9 |
C12H12BrN3O2 |
|
1,3-diethyl-1,3-dimethylurea |
31468-19-6 |
C7H16N2O |
|
Dapoxetine impurity 62 |
|
|
|
Dapoxetine impurity 56 |
|
|
|
N-[4-[[(2,4-ジアミノプテリジン-6-イル)メチル]メチルアミノ]ベンゾイル]-D-グルタミン酸 |
51865-79-3 |
C20H22N8O5 |
|
Bimatoprost Impurity 11 |
|
|
|
Bimatoprost Impurity 9 |
|
|
|
Dolutegravir Impurity 18 |
|
|
|
PeraMpanel |
380918-53-6 |
C23H15N3O |
|
Lenvatinib Impurity 33 |
|
|
|
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
|
Pitavastatin Impurity 71 |
|
|
|
Rosuvastatin EP Impurity M Sodium Salt |
|
|
|
Furosemide impurity 8 |
|
|
|
Febuxostat Impurity 108 |
|
|
|
Flucloxacillin EP Impurity J |
|
|
|
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
|
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
|
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
|
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
|
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
|
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
|
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
|
Vonoprazan Impurity B-2 |
|
|
|
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
|
Budesonide Impurity 31 |
|
|
|
Budesonide Impurity 23 |
|
|
|
Hexanoic acid, 3-(chloromethyl)-, (3R)- |
2101641-90-9 |
C7H13ClO2 |
|
Bisoprolol Impurity |
2226263-68-7 |
C18H31NO4 |
|
2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- |
1261219-83-3 |
C18H17NO4 |
|
Tofacitinib Impurity |
2504210-41-5 |
C29H38N10O2 |
|
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
|
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
|
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
|
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
|
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
|
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |
|
(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
|
|
|
(3R)-3α,4α-(1,3-ジベンジルウレイレン)テトラヒドロチオフェン-5-オン |
28092-52-6 |
C19H18N2O2S |
|
(2S)-2-ピロリジンカルボン酸メチル |
2577-48-2 |
C6H11NO2 |